 Austin Larson
Concepts (331)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurodevelopmental Disorders | 12 | 2024 | 155 | 2.370 |
Why?
| | Intellectual Disability | 8 | 2024 | 149 | 1.940 |
Why?
| | Congenital Disorders of Glycosylation | 7 | 2025 | 10 | 1.520 |
Why?
| | Abnormalities, Multiple | 7 | 2024 | 178 | 1.520 |
Why?
| | Mutation | 14 | 2025 | 3696 | 1.130 |
Why?
| | Bone Diseases, Developmental | 2 | 2024 | 16 | 0.980 |
Why?
| | Phenotype | 21 | 2025 | 3051 | 0.960 |
Why?
| | Mitochondrial Encephalomyopathies | 2 | 2020 | 8 | 0.850 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 2 | 2020 | 17 | 0.760 |
Why?
| | Mitochondrial Diseases | 4 | 2025 | 90 | 0.740 |
Why?
| | Diet, Ketogenic | 3 | 2021 | 35 | 0.740 |
Why?
| | Mitochondria | 6 | 2020 | 855 | 0.730 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 14 | 0.670 |
Why?
| | Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2019 | 6 | 0.660 |
Why?
| | Gray Matter | 1 | 2019 | 82 | 0.620 |
Why?
| | Dystroglycans | 1 | 2018 | 5 | 0.600 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 6 | 0.600 |
Why?
| | Infant | 24 | 2025 | 9001 | 0.590 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 34 | 0.590 |
Why?
| | Multiple Carboxylase Deficiency | 1 | 2018 | 1 | 0.590 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 84 | 0.560 |
Why?
| | Glycosylation | 8 | 2025 | 149 | 0.500 |
Why?
| | Phosphotransferases (Phosphomutases) | 3 | 2025 | 4 | 0.490 |
Why?
| | Acidosis, Lactic | 3 | 2024 | 45 | 0.490 |
Why?
| | Hypopituitarism | 1 | 2015 | 15 | 0.480 |
Why?
| | Child, Preschool | 23 | 2025 | 10487 | 0.470 |
Why?
| | Cardiomyopathies | 3 | 2024 | 336 | 0.470 |
Why?
| | Seizures | 5 | 2023 | 400 | 0.470 |
Why?
| | Developmental Disabilities | 3 | 2024 | 259 | 0.460 |
Why?
| | Adrenal Insufficiency | 3 | 2021 | 32 | 0.450 |
Why?
| | Xanthomatosis, Cerebrotendinous | 2 | 2024 | 3 | 0.450 |
Why?
| | Genetic Association Studies | 5 | 2025 | 361 | 0.440 |
Why?
| | Magnetic Resonance Imaging | 6 | 2020 | 3387 | 0.420 |
Why?
| | Prilocaine | 1 | 2013 | 4 | 0.420 |
Why?
| | Cephalometry | 1 | 2013 | 31 | 0.420 |
Why?
| | Methemoglobinemia | 1 | 2013 | 13 | 0.420 |
Why?
| | Dystocia | 1 | 2013 | 11 | 0.420 |
Why?
| | Lidocaine | 1 | 2013 | 38 | 0.410 |
Why?
| | Sexual Development | 1 | 2012 | 19 | 0.410 |
Why?
| | Fetal Macrosomia | 1 | 2013 | 62 | 0.400 |
Why?
| | Shoulder | 1 | 2013 | 86 | 0.400 |
Why?
| | Anesthetics, Local | 1 | 2013 | 74 | 0.400 |
Why?
| | Liver Transplantation | 1 | 2020 | 800 | 0.400 |
Why?
| | Humans | 60 | 2025 | 128495 | 0.380 |
Why?
| | Female | 39 | 2025 | 68266 | 0.370 |
Why?
| | DNA, Mitochondrial | 2 | 2024 | 190 | 0.370 |
Why?
| | Child | 29 | 2025 | 20805 | 0.370 |
Why?
| | Male | 37 | 2025 | 63043 | 0.340 |
Why?
| | Adolescent | 18 | 2025 | 20304 | 0.320 |
Why?
| | Heterozygote | 6 | 2024 | 269 | 0.320 |
Why?
| | Epilepsy | 3 | 2023 | 323 | 0.300 |
Why?
| | Infant, Newborn | 10 | 2025 | 5740 | 0.290 |
Why?
| | Transcription Factors | 4 | 2022 | 1635 | 0.290 |
Why?
| | Genetic Testing | 4 | 2023 | 428 | 0.280 |
Why?
| | Intestinal Pseudo-Obstruction | 2 | 2019 | 9 | 0.280 |
Why?
| | Genetic Variation | 3 | 2021 | 935 | 0.270 |
Why?
| | Nerve Tissue Proteins | 2 | 2021 | 570 | 0.270 |
Why?
| | Genetic Predisposition to Disease | 4 | 2019 | 2269 | 0.270 |
Why?
| | Mitochondrial Proteins | 2 | 2020 | 245 | 0.260 |
Why?
| | Nuclear Proteins | 2 | 2022 | 658 | 0.250 |
Why?
| | Carrier Proteins | 2 | 2019 | 732 | 0.240 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 385 | 0.240 |
Why?
| | Nervous System Malformations | 2 | 2022 | 37 | 0.240 |
Why?
| | Collagen Type VII | 1 | 2025 | 27 | 0.240 |
Why?
| | Actins | 2 | 2019 | 403 | 0.230 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 8 | 0.230 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2025 | 40 | 0.230 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 39 | 0.230 |
Why?
| | Loss of Function Mutation | 2 | 2021 | 39 | 0.230 |
Why?
| | Metabolism, Inborn Errors | 2 | 2021 | 40 | 0.230 |
Why?
| | Cholestanol | 1 | 2024 | 2 | 0.230 |
Why?
| | Bezafibrate | 1 | 2024 | 9 | 0.230 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 11 | 0.230 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 24 | 0.220 |
Why?
| | Sotos Syndrome | 1 | 2024 | 2 | 0.220 |
Why?
| | Septo-Optic Dysplasia | 1 | 2024 | 4 | 0.220 |
Why?
| | Megalencephaly | 1 | 2024 | 19 | 0.220 |
Why?
| | Niacinamide | 1 | 2024 | 73 | 0.220 |
Why?
| | Autistic Disorder | 2 | 2023 | 186 | 0.220 |
Why?
| | Craniofacial Abnormalities | 1 | 2024 | 63 | 0.210 |
Why?
| | Young Adult | 11 | 2025 | 12349 | 0.210 |
Why?
| | Chromosome Disorders | 1 | 2023 | 40 | 0.210 |
Why?
| | Aldehyde Reductase | 1 | 2023 | 28 | 0.210 |
Why?
| | Chromosome Deletion | 2 | 2023 | 102 | 0.200 |
Why?
| | Vestibular Diseases | 1 | 2023 | 25 | 0.200 |
Why?
| | Hematologic Diseases | 1 | 2023 | 60 | 0.200 |
Why?
| | Bile Acids and Salts | 1 | 2024 | 194 | 0.200 |
Why?
| | Cerebellar Diseases | 1 | 2022 | 22 | 0.200 |
Why?
| | De Lange Syndrome | 1 | 2022 | 2 | 0.200 |
Why?
| | RNA, Transfer | 2 | 2020 | 130 | 0.200 |
Why?
| | Phosphoproteins | 2 | 2021 | 329 | 0.190 |
Why?
| | Amino Acid Substitution | 2 | 2020 | 281 | 0.190 |
Why?
| | Transposases | 1 | 2022 | 16 | 0.190 |
Why?
| | Rhodanine | 1 | 2021 | 1 | 0.190 |
Why?
| | Thiazolidines | 1 | 2021 | 9 | 0.190 |
Why?
| | Biomarkers | 5 | 2024 | 3893 | 0.190 |
Why?
| | Dwarfism | 1 | 2021 | 15 | 0.190 |
Why?
| | Sorbitol | 1 | 2021 | 14 | 0.190 |
Why?
| | Fibroblasts | 4 | 2020 | 937 | 0.190 |
Why?
| | Zebrafish | 2 | 2023 | 464 | 0.190 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2020 | 487 | 0.190 |
Why?
| | Wolf-Hirschhorn Syndrome | 1 | 2021 | 2 | 0.190 |
Why?
| | Adult | 16 | 2025 | 35299 | 0.180 |
Why?
| | Metabolism | 1 | 2021 | 38 | 0.180 |
Why?
| | Methionine | 1 | 2021 | 157 | 0.180 |
Why?
| | Vitamin B 12 | 1 | 2021 | 122 | 0.180 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 112 | 0.180 |
Why?
| | Drosophila Proteins | 1 | 2022 | 187 | 0.180 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2021 | 115 | 0.180 |
Why?
| | Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2020 | 8 | 0.170 |
Why?
| | Receptors, CCR4 | 1 | 2020 | 21 | 0.170 |
Why?
| | Aldehyde-Lyases | 1 | 2020 | 2 | 0.170 |
Why?
| | Nephrosis | 1 | 2020 | 4 | 0.170 |
Why?
| | Vitamin B 6 | 1 | 2020 | 9 | 0.170 |
Why?
| | Prenatal Care | 1 | 2023 | 275 | 0.170 |
Why?
| | Adrenal Hyperplasia, Congenital | 1 | 2021 | 37 | 0.170 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 22 | 0.170 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.170 |
Why?
| | Mucolipidoses | 1 | 2020 | 7 | 0.170 |
Why?
| | Myotonin-Protein Kinase | 1 | 2020 | 1 | 0.170 |
Why?
| | Leigh Disease | 1 | 2020 | 19 | 0.170 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.170 |
Why?
| | Thymidine | 1 | 2020 | 59 | 0.170 |
Why?
| | ATP-Dependent Proteases | 1 | 2020 | 2 | 0.170 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2020 | 2 | 0.170 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 775 | 0.170 |
Why?
| | Muscular Diseases | 1 | 2020 | 107 | 0.170 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 279 | 0.170 |
Why?
| | Lymphopenia | 1 | 2020 | 59 | 0.170 |
Why?
| | Tumor Suppressor Proteins | 1 | 2022 | 313 | 0.170 |
Why?
| | Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 4 | 0.170 |
Why?
| | Tyrosine | 1 | 2020 | 218 | 0.170 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 26 | 0.170 |
Why?
| | Membrane Proteins | 2 | 2023 | 1109 | 0.170 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 42 | 0.160 |
Why?
| | Mutagenesis, Insertional | 1 | 2019 | 65 | 0.160 |
Why?
| | Albinism | 1 | 2019 | 2 | 0.160 |
Why?
| | Lysosomal Storage Diseases | 1 | 2019 | 4 | 0.160 |
Why?
| | Acids | 1 | 2019 | 16 | 0.160 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2021 | 125 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2022 | 683 | 0.160 |
Why?
| | Chloride Channels | 1 | 2019 | 38 | 0.160 |
Why?
| | Oligonucleotides, Antisense | 1 | 2019 | 106 | 0.160 |
Why?
| | Proteolysis | 1 | 2020 | 162 | 0.160 |
Why?
| | Scoliosis | 1 | 2021 | 201 | 0.160 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2018 | 54 | 0.160 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 121 | 0.160 |
Why?
| | Galactosyltransferases | 1 | 2018 | 11 | 0.150 |
Why?
| | Rare Diseases | 1 | 2019 | 100 | 0.150 |
Why?
| | Retrospective Studies | 7 | 2025 | 14471 | 0.150 |
Why?
| | Leukoencephalopathies | 1 | 2018 | 21 | 0.150 |
Why?
| | Bronchiectasis | 1 | 2020 | 108 | 0.150 |
Why?
| | Ehlers-Danlos Syndrome | 1 | 2018 | 16 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 135 | 0.150 |
Why?
| | Spasms, Infantile | 1 | 2020 | 122 | 0.150 |
Why?
| | Membrane Transport Proteins | 1 | 2019 | 149 | 0.150 |
Why?
| | Trachea | 1 | 2020 | 221 | 0.150 |
Why?
| | Fetus | 1 | 2023 | 765 | 0.150 |
Why?
| | Molecular Chaperones | 1 | 2020 | 182 | 0.150 |
Why?
| | Ubiquinone | 1 | 2018 | 28 | 0.150 |
Why?
| | Arginine | 1 | 2019 | 260 | 0.150 |
Why?
| | Nerve Degeneration | 1 | 2018 | 44 | 0.150 |
Why?
| | Ataxia | 1 | 2018 | 41 | 0.150 |
Why?
| | Enzyme Inhibitors | 1 | 2021 | 813 | 0.150 |
Why?
| | Metalloendopeptidases | 1 | 2018 | 59 | 0.150 |
Why?
| | Nephrotic Syndrome | 1 | 2018 | 28 | 0.150 |
Why?
| | Gene Expression | 2 | 2020 | 1455 | 0.150 |
Why?
| | Phenylalanine-tRNA Ligase | 1 | 2017 | 2 | 0.150 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2018 | 53 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2019 | 176 | 0.140 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2017 | 9 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 96 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2020 | 575 | 0.140 |
Why?
| | Carnitine | 1 | 2018 | 76 | 0.140 |
Why?
| | Muscle Weakness | 1 | 2018 | 83 | 0.140 |
Why?
| | Catalytic Domain | 1 | 2018 | 217 | 0.140 |
Why?
| | Colon | 2 | 2019 | 252 | 0.130 |
Why?
| | Urinary Bladder | 2 | 2019 | 175 | 0.130 |
Why?
| | Dietary Supplements | 1 | 2020 | 531 | 0.130 |
Why?
| | Pregnancy | 5 | 2023 | 6373 | 0.120 |
Why?
| | Precision Medicine | 1 | 2019 | 386 | 0.120 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.120 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 7 | 0.120 |
Why?
| | Human Growth Hormone | 1 | 2015 | 45 | 0.120 |
Why?
| | Cohort Studies | 3 | 2024 | 5402 | 0.120 |
Why?
| | Thyrotropin | 1 | 2015 | 109 | 0.120 |
Why?
| | Brain | 4 | 2020 | 2624 | 0.110 |
Why?
| | Hypogonadism | 1 | 2015 | 84 | 0.110 |
Why?
| | Muscle, Skeletal | 3 | 2020 | 1624 | 0.110 |
Why?
| | Histones | 1 | 2019 | 588 | 0.110 |
Why?
| | Introns | 2 | 2025 | 250 | 0.110 |
Why?
| | RNA | 1 | 2020 | 881 | 0.110 |
Why?
| | Mutation, Missense | 3 | 2021 | 315 | 0.110 |
Why?
| | Cephalopelvic Disproportion | 1 | 2013 | 2 | 0.110 |
Why?
| | Vacuum Extraction, Obstetrical | 1 | 2013 | 4 | 0.110 |
Why?
| | Port-Wine Stain | 1 | 2013 | 2 | 0.110 |
Why?
| | Rhode Island | 1 | 2013 | 26 | 0.100 |
Why?
| | Brachial Plexus | 1 | 2013 | 28 | 0.100 |
Why?
| | WT1 Proteins | 1 | 2012 | 14 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2064 | 0.100 |
Why?
| | Administration, Topical | 1 | 2013 | 144 | 0.100 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 24 | 0.100 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 52 | 0.100 |
Why?
| | Homozygote | 2 | 2025 | 193 | 0.100 |
Why?
| | Drosophila | 2 | 2023 | 142 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2022 | 3339 | 0.090 |
Why?
| | Syndrome | 2 | 2022 | 336 | 0.090 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 57 | 0.090 |
Why?
| | Urban Population | 1 | 2013 | 441 | 0.080 |
Why?
| | Haploinsufficiency | 2 | 2020 | 48 | 0.080 |
Why?
| | DNA Mutational Analysis | 2 | 2021 | 385 | 0.080 |
Why?
| | Oxidative Phosphorylation | 2 | 2020 | 186 | 0.080 |
Why?
| | Electron Transport | 2 | 2020 | 112 | 0.080 |
Why?
| | Diabetes, Gestational | 1 | 2013 | 308 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1412 | 0.080 |
Why?
| | Prospective Studies | 3 | 2025 | 7069 | 0.070 |
Why?
| | Proteomics | 2 | 2024 | 1018 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 819 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2021 | 1005 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1423 | 0.060 |
Why?
| | Middle Aged | 5 | 2025 | 30921 | 0.060 |
Why?
| | Biopsy | 2 | 2019 | 1079 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.060 |
Why?
| | Genes, Recessive | 1 | 2025 | 76 | 0.060 |
Why?
| | Exome | 2 | 2017 | 220 | 0.060 |
Why?
| | Cholestanols | 1 | 2024 | 1 | 0.060 |
Why?
| | Chenodeoxycholic Acid | 1 | 2024 | 14 | 0.060 |
Why?
| | NFI Transcription Factors | 1 | 2024 | 8 | 0.060 |
Why?
| | Cholestanetriol 26-Monooxygenase | 1 | 2023 | 7 | 0.060 |
Why?
| | Tertiary Care Centers | 1 | 2024 | 150 | 0.050 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2023 | 19 | 0.050 |
Why?
| | Goals | 1 | 2025 | 160 | 0.050 |
Why?
| | Mannose | 1 | 2023 | 25 | 0.050 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5045 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2022 | 2679 | 0.050 |
Why?
| | Animals | 5 | 2023 | 34647 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 324 | 0.050 |
Why?
| | Histone Demethylases | 1 | 2023 | 31 | 0.050 |
Why?
| | Cause of Death | 1 | 2025 | 392 | 0.050 |
Why?
| | Exons | 1 | 2024 | 339 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 17 | 0.050 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 32 | 0.050 |
Why?
| | Workflow | 1 | 2023 | 154 | 0.050 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 22 | 0.050 |
Why?
| | Patient Acuity | 1 | 2021 | 45 | 0.050 |
Why?
| | Neuroglia | 1 | 2022 | 166 | 0.050 |
Why?
| | Language Development Disorders | 1 | 2021 | 45 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2024 | 428 | 0.050 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 370 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 375 | 0.050 |
Why?
| | Face | 1 | 2023 | 165 | 0.050 |
Why?
| | Hepatocytes | 1 | 2022 | 213 | 0.050 |
Why?
| | Echocardiography | 1 | 2024 | 624 | 0.050 |
Why?
| | Homocysteine | 1 | 2021 | 149 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2022 | 231 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 137 | 0.040 |
Why?
| | Methylation | 1 | 2021 | 227 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 42 | 0.040 |
Why?
| | Aged | 3 | 2025 | 21974 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 234 | 0.040 |
Why?
| | Acyl-CoA Dehydrogenase | 1 | 2020 | 8 | 0.040 |
Why?
| | Frameshift Mutation | 1 | 2020 | 31 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2020 | 14 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2024 | 1817 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 174 | 0.040 |
Why?
| | Cell Nucleolus | 1 | 2019 | 17 | 0.040 |
Why?
| | Protein Stability | 1 | 2020 | 160 | 0.040 |
Why?
| | Facies | 1 | 2019 | 21 | 0.040 |
Why?
| | Drugs, Investigational | 1 | 2019 | 32 | 0.040 |
Why?
| | Feeding and Eating Disorders | 1 | 2021 | 146 | 0.040 |
Why?
| | Heme | 1 | 2020 | 76 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2022 | 401 | 0.040 |
Why?
| | Phosphates | 1 | 2020 | 169 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 96 | 0.040 |
Why?
| | Leukemia | 1 | 2021 | 228 | 0.040 |
Why?
| | Risk Factors | 1 | 2013 | 9737 | 0.040 |
Why?
| | 14-3-3 Proteins | 1 | 2018 | 17 | 0.040 |
Why?
| | Aneuploidy | 1 | 2019 | 92 | 0.040 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 23 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 208 | 0.040 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2019 | 98 | 0.040 |
Why?
| | Brain Diseases | 1 | 2020 | 137 | 0.040 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 130 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2018 | 25 | 0.040 |
Why?
| | Critical Illness | 1 | 2024 | 755 | 0.040 |
Why?
| | Drug Discovery | 1 | 2019 | 130 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 326 | 0.040 |
Why?
| | Oocytes | 1 | 2019 | 174 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 581 | 0.040 |
Why?
| | Dermis | 1 | 2018 | 31 | 0.040 |
Why?
| | Iron-Sulfur Proteins | 1 | 2018 | 26 | 0.040 |
Why?
| | Metabolomics | 1 | 2023 | 602 | 0.040 |
Why?
| | Weight Gain | 1 | 2021 | 504 | 0.040 |
Why?
| | Aminoacylation | 1 | 2017 | 12 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 541 | 0.040 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2017 | 30 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 1 | 2018 | 189 | 0.030 |
Why?
| | Alleles | 1 | 2020 | 842 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 621 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 279 | 0.030 |
Why?
| | Electroencephalography | 1 | 2019 | 396 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 715 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2719 | 0.030 |
Why?
| | Pedigree | 1 | 2018 | 485 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1623 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1003 | 0.030 |
Why?
| | Caregivers | 1 | 2023 | 813 | 0.030 |
Why?
| | Neurons | 1 | 2024 | 1447 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2020 | 2044 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 983 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 479 | 0.030 |
Why?
| | Family | 1 | 2020 | 649 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 222 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2024 | 4874 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 455 | 0.030 |
Why?
| | Skin | 1 | 2019 | 717 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1830 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 671 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 377 | 0.030 |
Why?
| | Mice | 2 | 2023 | 16620 | 0.030 |
Why?
| | DNA Methylation | 1 | 2019 | 607 | 0.030 |
Why?
| | Liver | 1 | 2022 | 1827 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2018 | 524 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3780 | 0.030 |
Why?
| | Muscle, Smooth | 1 | 2014 | 152 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2018 | 603 | 0.020 |
Why?
| | Kidney | 1 | 2018 | 1310 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2517 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4017 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2864 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2018 | 10162 | 0.010 |
Why?
|
|
Larson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|